论文部分内容阅读
目的:评价我院癌症住院患者麻醉性镇痛药的应用情况及趋势。方法:对我院2005～2008年癌症住院患者麻醉性镇痛药的销售金额、用药人数、处方等进行统计、分析结果:10 mg硫酸吗啡控释片不是医患钟情的品规,芬太尼透皮贴、30 mg吗啡缓释片的销售金额、用药频度排序4年来稳居前列;普通吗啡片在保持销量稳步增长的同时,处方量无明显变化,但人均消耗量却在增长。二阶梯镇痛药布桂嗪片销量不断下降;吗啡注射液和布桂嗪注射液的销量总体呈下降趋势。结论:我院癌症住院患者麻醉性镇痛药应用符合《癌症三阶梯止痛指导原则》。
Objective: To evaluate the application and trend of narcotic analgesics in cancer inpatients in our hospital. Methods: The amount of sales of narcotic analgesics in patients with cancer inpatients in our hospital from 2005 to 2008, the number of patients treated, prescriptions and other statistics, the results of the analysis: 10 mg morphine sulfate controlled-release tablets is not a doctor-patient products, fentanyl Transdermal patches, 30mg morphine sustained-release tablets sales amount, the frequency of medication ranked the forefront of four years; ordinary morphine tablets to maintain steady growth in sales at the same time, no significant change in prescription volume, but the per capita consumption is growing. Sales of two-step analgesic buzaucin tablets continued to decline; the sales volume of morphine and buprofen injections showed a general downward trend. Conclusion: The application of narcotic analgesics in cancer inpatients in our hospital is in accordance with the Guiding Principles of Three-Step Cancer Pain Relief.